AIN457 (secukinumab) can considerably improve the symptoms of moderate-to-severe plaque psoriasis on the feet, hands and nails when taken once weekly during the first four weeks of treatment, compared to placebo therapy, Swiss pharmaceutical giant Novartis announced today. Novartis added that the patients on secukinumab enjoyed improved quality of life by the twelfth week of therapy. Prof...
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment